Claudin18.2 Antibody / Gastrointestinal Cancer Marker [clone CLDN18.2/8559R] (V5010)

Claudin18.2 Antibody Pancreas Tissue WB. Western blot analysis of human pancreas tissue lysate using Claudin18.2 Antibody / Gastrointestinal Cancer Marker clone CLDN18.2/8559R. A major band is detected near approximately 30-35 kDa, consistent with the expected molecular weight range of Claudin18.2, a tight junction-associated transmembrane protein expressed in gastrointestinal epithelial tissues. An additional higher molecular weight band near approximately 45 kDa may represent modified, partially oligomerized, or alternatively processed Claudin18.2-associated species commonly observed with membrane-associated junctional proteins.

Claudin18.2 Antibody Pancreas IHC. Immunohistochemistry analysis of FFPE human pancreas tissue stained with Claudin18.2 Antibody / Gastrointestinal Cancer Marker clone CLDN18.2/8559R. Strong membranous and cytoplasmic HRP-DAB brown staining is observed in pancreatic epithelial cells, consistent with the tight junction-associated localization expected for Claudin18.2/CLDN18.2 in gastrointestinal epithelial tissues and pancreatic cancer-associated biology. The inset image shows a PBS-only negative control processed without primary antibody, confirming minimal non-specific background staining. Sections underwent HIER using 10mM Tris with 1mM EDTA buffer, pH 9, prior to immunostaining.

Claudin18.2 Antibody A431 and A549 WB. Western blot analysis of human A431 and A549 cell lysates using Claudin18.2 Antibody / Gastrointestinal Cancer Marker clone CLDN18.2/8559R. A distinct band is detected at approximately 27-28 kDa, consistent with the predicted molecular weight of Claudin18.2, a tight junction-associated transmembrane protein implicated in gastric and pancreatic cancer biology.